Fagron Sterile Services,
a solution you can rely on.
State-of-the-art 503B, reliable medication supply
Fagron Sterile Services US (FSS) is a DEA and FDA-registered supplier, providing a broad portfolio of high-quality sterile medication and expertise in pharmaceutical manufacturing, repackaging, patient safety, regulatory guidance and pharmacy.
means same-day shipping on >97% of orders placed before cutoff times
100% of Batches Tested
for sterility, particulate matter and potency to support patient safety
Stability Indicating Testing
methods for expiration dates, validated according to cGMP requirements
Quality is at the center of everything we do
Our values give us standards to measure ourselves by, particularly in our dealings with customers, suppliers, team members and the wider world.
Explore our sterile outsourcing services
Doses are produced with industry-leading automation and quality control systems, so you and your patients can count on FSS — one of the most advanced DEA and FDA-registered 503B outsourcing providers in the United States.
Operating room (OR) anesthesia
Reduce waste and cut down on the number of touchpoints in surgery preparation. FSS' pre-filled, ready-to-administer OR anesthesia solutions meet stringent quality testing processes developed across three decades.
Support safety and improved efficiency with high-quality ophthalmic products. Ask about our Avastin® purchase programs and other solutions.
Give your patients peace of mind with preservative-free corticosteroids. We offer unit-of-use alternatives made under stringent cGMP guidelines.
From topical anesthesia to urology (mitoMYcin-bladder) and dialysis, FSS provides outsourcing solutions prepared in state-of-the-art cleanroom environments.
Trade shows & events
Each year, FSS supports over 50 healthcare, pharmacy, ophthalmology and anesthesia organizations by sponsoring trade shows and virtual events across the United States. Our team is always available to meet, listen and partner with you!
Catch up on the latest FSS product updates, company news and industry information.
Sean Jones, MBA
Feb 6, 2023